Aventis Pharma S.A.

Research and Markets Adds: Special Report: Successes and Lessons Learned in the Pharmaceutical Industry.
Health & Beauty Close-Up; 1/6/2010; 944 words; ...success for Japanese pharma lies, in part, in expanding...scale? Why do Japanese pharma tend to lose out in acquisition...Pharmaceuticals - Alcon - Aventis - Bayer - Bayer Schering Pharma - Biogen Idec - Bio Products...Jones - Dr. Reddy's Laboratories - Kyowa...

NovaDel Receives Issue Notification for New U.S. Patent Covering its Oral Spray Drug Delivery Technology.
Information Technology Business; 1/5/2010; 1182 words; ...nine patents in the U.S., three patents in Canada...prepared to get a full night's sleep (7-8 hours...registered trademark of sanofi-aventis. About NovaDel Pharma NovaDel Pharma Inc. is...marketed drugs. The Company's proprietary technology...

Lung Cancer Therapeutics Market Outlook and Pipeline Analysis - Key Late-Phase Products Have A Forecast Sales Potential Of Up To $5651m By 2015.
M2 Presswire; 1/5/2010; 1010 words; ...key lung cancer therapies: - Sanofi-Aventis' Taxotere (docetaxel) - Eli-Lilly's Gemzar (gemcitabine) - Eli-Lilly...will go on to compete well with Roche's Avastin and OSI Pharma/Roche's Tarceva (erlotinib). Purchasing this...

Research and Markets: Lung Cancer Therapeutics Market Outlook and Pipeline Analysis - Key Late-Phase Products Have A Forecast Sales Potential of up to $5651m by 2015.
Business Wire; 1/5/2010; 1050 words; ...key lung cancer therapies: * Sanofi-Aventis' Taxotere (docetaxel) * Eli-Lilly's Gemzar (gemcitabine) * Eli-Lilly...will go on to compete well with Roche's Avastin and OSI Pharma/Roche's Tarceva (erlotinib). Purchasing this...

Reportlinker Adds Multiplex Assays: Evolving Technologies, Applications and Future Directions.
PR Newswire; 1/4/2010; 1219 words; ...attacking an individual's body or producing an exaggerated...Bowel Disease-Crohn's Disease and Ulcerative...Bowel Disease-Crohn's Disease and Ulcerative...Group) 5.23. Sanofi-Aventis 5.24. Takeda Pharmaceutical...Pharmaceuticals 8.3. Astellas Pharma 8.4. Bristol-Myers...